Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension

氧化应激 活性氧 药理学 缺氧(环境) 促炎细胞因子 癌症研究 化学 线粒体 细胞生长 炎症 生物 医学 生物化学 内科学 氧气 有机化学
作者
Ryo Kurosawa,Kimio Satoh,Nobuhiro Kikuchi,Haruhisa Kikuchi,Daisuke Saigusa,M. Al-Mamun,Mohammad Abdul Hai Siddique,Junichi Omura,Taijyu Satoh,Shinichiro Sunamura,Masamichi Nogi,Kazuhiko Numano,Satoshi Miyata,Akira Uruno,Kuniyuki Kano,Yotaro Matsumoto,Takayuki Doi,Junken Aoki,Yoshiteru Oshima,Masayuki Yamamoto,Hiroaki Shimokawa
出处
期刊:Circulation Research [Lippincott Williams & Wilkins]
卷期号:125 (3): 309-327 被引量:36
标识
DOI:10.1161/circresaha.119.315229
摘要

Pulmonary arterial hypertension (PAH) is characterized by enhanced proliferation of pulmonary artery smooth muscle cells (PASMCs) accompanying increased production of inflammatory factors and adaptation of the mitochondrial metabolism to a hyperproliferative state. However, all the drugs in clinical use target pulmonary vascular dilatation, which may not be effective for patients with advanced PAH.We aimed to discover a novel drug for PAH that inhibits PASMC proliferation.We screened 5562 compounds from original library using high-throughput screening system to discover compounds which inhibit proliferation of PASMCs from patients with PAH (PAH-PASMCs). We found that celastramycin, a benzoyl pyrrole-type compound originally found in a bacteria extract, inhibited the proliferation of PAH-PASMCs in a dose-dependent manner with relatively small effects on PASMCs from healthy donors. Then, we made 25 analogs of celastramycin and selected the lead compound, which significantly inhibited cell proliferation of PAH-PASMCs and reduced cytosolic reactive oxygen species levels. Mechanistic analysis demonstrated that celastramycin reduced the protein levels of HIF-1α (hypoxia-inducible factor 1α), which impairs aerobic metabolism, and κB (nuclear factor-κB), which induces proinflammatory signals, in PAH-PASMCs, leading to reduced secretion of inflammatory cytokine. Importantly, celastramycin treatment reduced reactive oxygen species levels in PAH-PASMCs with increased protein levels of Nrf2 (nuclear factor erythroid 2-related factor 2), a master regulator of cellular response against oxidative stress. Furthermore, celastramycin treatment improved mitochondrial energy metabolism with recovered mitochondrial network formation in PAH-PASMCs. Moreover, these celastramycin-mediated effects were regulated by ZFC3H1 (zinc finger C3H1 domain-containing protein), a binding partner of celastramycin. Finally, celastramycin treatment ameliorated pulmonary hypertension in 3 experimental animal models, accompanied by reduced inflammatory changes in the lungs.These results indicate that celastramycin ameliorates pulmonary hypertension, reducing excessive proliferation of PAH-PASMCs with less inflammation and reactive oxygen species levels, and recovered mitochondrial energy metabolism. Thus, celastramycin is a novel drug for PAH that targets antiproliferative effects on PAH-PASMCs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞飞完成签到,获得积分10
2秒前
2秒前
香芋完成签到,获得积分10
4秒前
4秒前
5秒前
科研通AI65的应助被JH_Yang采纳,获得10
5秒前
勤劳时光完成签到,获得积分10
6秒前
wangliufang完成签到,获得积分20
7秒前
达芬岐完成签到,获得积分10
7秒前
7秒前
8秒前
yzx完成签到,获得积分10
8秒前
佘炭炭发布了新的文献求助10
9秒前
13秒前
iNk的应助被fxl采纳,获得10
13秒前
傻丢发布了新的文献求助10
14秒前
14秒前
15秒前
16秒前
Aether3发布了新的文献求助10
16秒前
16秒前
16秒前
16秒前
17秒前
17秒前
17秒前
17秒前
酷波er的应助被嘻嘻哈哈顺利采纳,获得10
17秒前
18秒前
18秒前
18秒前
18秒前
19秒前
如风随水完成签到,获得积分10
19秒前
19秒前
19秒前
爆米花的应助被τ涛采纳,获得10
19秒前
19秒前
机灵花生完成签到,获得积分10
20秒前
经竺发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192841
求助须知:如何正确求助?哪些是违规求助? 9579236
关于积分的说明 21864289
捐赠科研通 7792410
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483927